Cardiff Oncology, Inc.
CRDF
$4.00
$0.051.27%
12/31/2024 | 09/30/2024 | ||||
---|---|---|---|---|---|
Revenue | -8.48% | 1.23% | |||
Total Other Revenue | -- | -- | |||
Total Revenue | -8.48% | 1.23% | |||
Cost of Revenue | 0.75% | 1.55% | |||
Gross Profit | -0.91% | -1.55% | |||
SG&A Expenses | -3.68% | -2.77% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | -0.34% | 0.46% | |||
Operating Income | 0.23% | -0.45% | |||
Income Before Tax | 0.57% | -0.65% | |||
Income Tax Expenses | -- | -- | |||
Earnings from Continuing Operations | 0.57% | -0.65% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | 0.57% | -0.65% | |||
EBIT | 0.23% | -0.45% | |||
EBITDA | 0.19% | -0.48% | |||
EPS Basic | 14.07% | 3.73% | |||
Normalized Basic EPS | 14.04% | 3.71% | |||
EPS Diluted | 14.07% | 3.73% | |||
Normalized Diluted EPS | 14.04% | 3.71% | |||
Average Basic Shares Outstanding | 15.69% | 4.55% | |||
Average Diluted Shares Outstanding | 15.69% | 4.55% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |